ERICK HUARCAYA: Open Payments
NPI 1245379288 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 19 payments from 12 companies in 2025. Trend: 2023 $1,158 · 2024 $1,690 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
| QIAGEN, LLC | 2 | $64 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Viatris Specialty LLC | 2 | $41 |
| Dexcom, Inc. | 1 | $36 |
| Amgen Inc. | 2 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: Kerendia, INJECTAFER, YUPELRI, Dexcom G6 Transmitter, OTEZLA, JOURNAVX, AIRSUPRA, RECORLEV.
Industry payments across AZ — which companies pay providers there.
